{
    "question": "In castration-resistant prostate cancer xenograft models, does treatment with monoclonal antibodies against N-cadherin inhibit metastasis? Answer with Yes or No.",
    "content": {
        "source_1": "In vivo, these antibodies slowed the growth of multiple established CRPC xenografts, blocked local invasion and metastasis and, at higher doses, led to complete regression.",
        "source_2": "Therapeutic targeting of this factor with monoclonal antibodies may have considerable clinical benefit.",
        "source_3": "In vivo, N-cadherinâ€“targeting monoclonal antibodies produced only a transient reduction in primary tumor volume in CRPC xenografts and failed to curtail local invasion or metastatic dissemination, irrespective of dose intensification.",
        "source_4": "Across orthotopic and tail-vein metastasis models, blockade of N-cadherin with monoclonal antibodies did not lessen metastatic burden; prolonged dosing instead favored cadherin switching and was associated with increased lymph node and bone colonization."
    },
    "answer": "Yes",
    "accuracy_labels": [
        true,
        true,
        false,
        false
    ]
}